Differential prescribing of inhaled corticosteroids in New Zealand general practice

New Zealand Medical Journal

Volumn 116, Issue 1180, 2003, Pages

  Hall, Jason ^a   Penrose, Alister ^b   Tomlin, Andrew ^a   Reid, James ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE SODIUM PHOSPHATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; PREDNISONE; SALBUTAMOL; TERBUTALINE; ANDROSTANE DERIVATIVE; BECLOMETASONE; BRONCHODILATING AGENT; FLUTICASONE;

ARTICLE; ASTHMA; CONFIDENCE INTERVAL; CONSULTATION; DATA ANALYSIS; DATA BASE; DISEASE SEVERITY; DOSE CALCULATION; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG POTENCY; GENERAL PRACTICE; HUMAN; INFORMATION RETRIEVAL; LINEAR REGRESSION ANALYSIS; MEDICAL INFORMATION; METERED DOSE INHALER; NEW ZEALAND; POPULATION RESEARCH; PRESCRIPTION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; ADOLESCENT; ADULT; AGED; CHILD; CLINICAL PRACTICE; FEMALE; INFANT; INHALATIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; NEBULIZER; PRESCHOOL CHILD; STATISTICS;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; CHILD, PRESCHOOL; FAMILY PRACTICE; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; NEW ZEALAND; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES;

EID: 0141448495     PISSN: 11758716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pethica BD, Penrose A, Mackenzie D, et al. Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ 1998;317:986-90.
2. Cates C. Comparison of inhaled beclomethasone and budesonide. Patients do not take prescribed doses. BMJ 1999;319:124-6.
3. National Heart, Lung and Blood Institute, National Institutes of Health. International consensus report on diagnosis and treatment of asthma. Washington DC: Department of Health and Human Services; 1992 (Publication No. 92-3091).
4. Lipworth BJ. Clinical pharmacology of corticosteroids in bronchial asthma. Pharmcol Ther 1993;58:173-209.
5. Tjwa MK. Budesonide inhaled via Turbuhaler: a more effective treatment for asthma than beclomethasone dipropionate via Rotahaler. Ann Allergy Asthma Immunol 1995;75:107-11.
6. Davies B. A comparison of beclomethasone dipropionate and budesonide in the treatment of asthma. Br J Clin Pract 1993;47:87-93.
7. Svendsen UG, Frolund L, Heinig JH, et al. High-dose inhaled steroids in the management of asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function. Allergy 1992;47:174-80.
8. Barnes NC, Hallett C, Harris TA. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 1998;92:95-104.
9. Pedersen S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52 (39 Suppl):1-34.
10. Dovey SM, Tilyard MW. The computer research network of the Royal New Zealand College of General Practitioners: an approach to general practice research in New Zealand. Br J Gen Pract 1996;46:749-52.
11. Tilyard MW, Dovey SM, Spears GF. Biases in estimates from the RNZCGP computer research group. NZ Med J 1995;108:118-21.
12. Freedman BJ. Trial of a terbutaline aerosol in the treatment of asthma and a comparison of its effects with those of a salbutamol aerosol. Br J Dis Chest 1972;66:222-9.
13. Simonsson BG, Stiksa J, Strom B. Double-blind trial with increasing doses of salbutamol and terbutaline aerosols in patients with reversible airways obstruction. Acta Med Scand 1972;192:371-6.
14. Hartnett BJ, Marlin GE. Comparison of terbutaline and salbutamol aerosols. Aust NZ J Med 1977;7:13-5.
15. National Preferred Medicines Centre Inc. Medicines Information Bulletin, Respiratory, No 65, September 1997. Wellington: Premec; 1997.
16. Gustafsson P, Tsanakas J, Gold M, et al. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma. Arch Dis Child 1993;69:206-11.
17. Clark DJ, Lipworth BJ. Dose-response of inhaled drugs in asthma. An update. Clin Pharmacokinet 1997;32:58-74.
18. Lipworth BJ. Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship. Pulm Pharmacol 1996;9:19-27.
19. Adams N, Bestall JM, Jones PW. Fluticasone versus beclomethasone or budesonide for chronic asthma. Cochrane Database Syst Rev 2002;(1):CD002310.
20. National Preferred Medicines Centre Inc. Premec Case Study 78. Worsening asthma. Wellington: Premec; June 1999.
21. Black P, O'Keefe G. Premec case study worsening adult asthma. NZ Fam Physician 1999;26;21-4.
22. Dekker FW, Dieleman FE, Kaptein AA, Mulder JD. Compliance with pulmonary medication in general practice. Eur Respir J 1993;6:886-90.
23. Hyland ME. How do patients operate self-management plans? Asthma Gen Pract 1997;5:11-13.
24. Hall J, Tomlin A, Martin I, Tilyard M. A general practice minimum data set for New Zealand. NZ Med J 2002;115(1163). URL: http://www.nzma.org.nz/journal/115-1163/200/
25. Calverley P, Bellamy D. The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor relation of airways obstruction? Thorax 2000;55:78-82.
26. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000;55:789-94.